Active Investments

The Public Health Company

Private

Devoted Health

Private

Element Biosciences

Private

Inscripta

Private

Suki

Private

Encoded Therapeutics

Private

Lyra Health

Private

Stride Health

Private

10X Genomics

Public (NYSE: TXG)

Grand Rounds Health

Private

Kyruus

Private

Hua Medicine

Public (SEHK: HKSE)

CloudFlare

Public (NASDAQ: NET)

Castlight Health

Public (NYSE: CSLT)

Alumni Investments

Doctor On Demand

Merged with Grand Rounds Health

PowerVision

Acquired by Alcon

Ariosa Diagnostics

Acquired by Roche

Fate Therapeutics

Public (NASDAQ: FATE)

Zeltiq

Public (NASDAQ: ZLTQ)

Receptos

Public (NASDAQ: RCPT)

Ikaria

Acquired by Mallinckrodt Pharmaceuticals

Achaogen

Public (NASDAQ: AKAO)

CodeRyte

Acquired by 3M

Sirna Therapeutics

Acquired by Merck

Ensure Medical

Acquired by Cordis

Vitae Pharma

Acquired by Allergan

XenoPort

Public (NASDAQ: XNPT)

athenahealth

Public (NASDAQ: ATHN)

Ironwood Pharma

Public (NASDAQ: IRWD)

Illumina

Public (NASDAQ: ILMN)

Bryan Roberts Partner

Focus Areas: Biotechnology, Diagnostics, Genomics, Healthcare IT, Medical Devices
Location: Palo Alto

Bryan joined Venrock in 1997. He is based in Palo Alto and seeks to partner with early-stage entrepreneurs innovating across the healthcare and life sciences industries. Bryan is currently involved with several companies across therapeutics, genomics, and HCIT, including 10X Genomics, Devoted Health, Element Biosciences, Encoded Therapeutics, Grand Rounds, and Lyra Health. Past investments include Ariosa Diagnostics (acquired by Roche), athenahealth (NASDAQ: ATHN), Ikaria (acquired by Mallinckrodt), Illumina (NASDAQ: ILMN), Ironwood Pharmaceuticals (NASDAQ: IRWD), Sirna Therapeutics (acquired by Merck), and Zeltiq (acquired by Allergan).

Immediately prior to joining Venrock, Bryan received his Ph.D. in Chemistry & Chemical Biology from Harvard University. He received his B.A. from Dartmouth College.

Podcasts

Writing

News

Active Companies

The Public Health Company

Devoted Health

Element Biosciences

Inscripta

Inscripta offers the world’s first benchtop platform for scalable Digital Genome Engineering to address the current challenges and limitations of gene editing.

Suki

Suki™ is an artificial intelligence-powered, voice-enabled digital assistant for doctors.

Encoded Therapeutics

Lyra Health

Stride Health

10X Genomics

10X Genomics provides an innovative genomics platform that delivers additional genetic information by dramatically upgrading the capabilities of existing short read sequencers.

Grand Rounds Health

Kyruus

Kyruus delivers provider search, scheduling, and data management solutions that help health systems match patients with the right providers.

Hua Medicine

CloudFlare

Castlight Health

Alumni Companies

Doctor On Demand

PowerVision

Ariosa Diagnostics

Fate Therapeutics

Zeltiq

Receptos

Ikaria

Achaogen

CodeRyte

Sirna Therapeutics

Ensure Medical

Vitae Pharma

Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, efficient and effective platform for drug design and development.

XenoPort

athenahealth

Ironwood Pharma

Illumina

Illumina has developed a comprehensive line of products that address the scale of experimentation and the breadth of functional analysis required to achieve the goals of molecular medicine.